Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07PSW
|
|||
Former ID |
DNC004077
|
|||
Drug Name |
N-(4-Phenyl-pyridin-2-yl)-guanidine
|
|||
Synonyms |
CHEMBL54467; N-(4-Phenyl-pyridin-2-yl)-guanidine; Guanidine, N-(4-phenyl-2-pyridinyl)-; 2-(4-Phenyl-2-pyridinyl)guanidine; BDBM50108355
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C12H12N4
|
|||
Canonical SMILES |
C1=CC=C(C=C1)C2=CC(=NC=C2)N=C(N)N
|
|||
InChI |
1S/C12H12N4/c13-12(14)16-11-8-10(6-7-15-11)9-4-2-1-3-5-9/h1-8H,(H4,13,14,15,16)
|
|||
InChIKey |
LQYVUDQYWIIZAV-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Tissue-type plasminogen activator (PLAT) | Target Info | Inhibitor | [1] |
KEGG Pathway | Complement and coagulation cascades | |||
Transcriptional misregulation in cancer | ||||
NetPath Pathway | IL5 Signaling Pathway | |||
Panther Pathway | Blood coagulation | |||
Plasminogen activating cascade | ||||
Pathwhiz Pathway | Coagulation | |||
Pathway Interaction Database | amb2 Integrin signaling | |||
Beta2 integrin cell surface interactions | ||||
Reactome | Dissolution of Fibrin Clot | |||
WikiPathways | Senescence and Autophagy in Cancer | |||
Complement and Coagulation Cascades | ||||
Endochondral Ossification | ||||
Blood Clotting Cascade | ||||
Dissolution of Fibrin Clot | ||||
Folate Metabolism | ||||
Vitamin B12 Metabolism | ||||
Selenium Micronutrient Network |
References | Top | |||
---|---|---|---|---|
REF 1 | Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 1: 2-Pyridinylguanidines. Bioorg Med Chem Lett. 2002 Jan 21;12(2):181-4. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.